| 2004 |
Menin associates with a trithorax-family histone methyltransferase complex containing MLL2 and Ash2L that methylates histone H3 on lysine 4; menin is bound to the Hoxc8 locus by chromatin immunoprecipitation, and Men1 knockout cells show decreased Hoxc8 expression. |
Co-immunoprecipitation, histone methyltransferase activity assay, chromatin immunoprecipitation (ChIP), Men1 knockout mouse/cell analysis |
Molecular cell |
High |
14992727
|
| 2000 |
Smad1 physically interacts with Hoxc8 through two regions within its amino-terminal 87 amino acids; one of these regions binds the Hoxc8 homeodomain. Overexpression of these Smad1 interaction domains activates osteopontin transcription and induces osteoblast differentiation and mineralized bone matrix formation in 2T3 cells. |
Yeast two-hybrid, gel-shift (EMSA), deletion analysis, transient and stable transfection assays, alkaline phosphatase/mineralization readouts |
The Journal of biological chemistry |
High |
10625647
|
| 1993 |
Hoxc8 protein binds DNA sequences in native chromatin and regulates expression of target genes including the mouse homologue of the Drosophila tumour-suppressor gene l(2)gl, identified by immunopurification of chromatin-bound DNA. |
Immunopurification of DNA bound to Hoxc8 in native chromatin (chromatin-IP precursor approach) |
Nature |
Medium |
8103190
|
| 1998 |
Overexpression of a Hoxc8 transgene in mice causes cartilage defects characterized by accumulation of proliferating chondrocytes and reduced maturation, demonstrating that Hoxc8 controls the progression of cells along the chondrocyte differentiation pathway in a dosage-dependent and Hox-class-specific manner. |
Transgenic mouse overexpression with skeletal histological and cartilage-maturation phenotypic analysis; comparison with Hoxd4 and Isl-1 transgenics |
Proceedings of the National Academy of Sciences of the United States of America |
High |
9707582
|
| 2005 |
Hoxc8 directly binds the osteopontin (OPN/Spp1) promoter in vivo (confirmed by ChIP), repressing its expression ~4.8-fold; Hoxc8 also directly binds regulatory regions of five other genes (including Fzd2) involved in oncogenesis, cell adhesion, proliferation, and apoptosis. |
Mouse oligonucleotide microarray (16,463 genes), chromatin immunoprecipitation (ChIP) of endogenous Hoxc8 at target gene promoters |
Proceedings of the National Academy of Sciences of the United States of America |
High |
15699330
|
| 1995 |
A 135 bp early neural tube (ENT) enhancer located ~3 kb upstream of Hoxc8 directs posterior neural tube expression via four interdependent combinatorial elements (A–D); element A is essential but requires interaction with at least two of B, C, or D for activity. |
Deletion analysis and nucleotide substitution mutagenesis in transgenic mouse reporter assays |
Development (Cambridge, England) |
High |
8575334
|
| 1996 |
A fifth cis-acting element (E) in the Hoxc8 early enhancer directs mesoderm expression in combination with elements A–D; different element combinations determine tissue-specific expression (neural tube: ABC/ABD/ACD; somite: ACDE; lateral plate mesoderm: DE), and mutations cause posteriorization of reporter expression. |
Transgenic mouse reporter assay with systematic cis-element mutation combinations |
Proceedings of the National Academy of Sciences of the United States of America |
High |
8901587
|
| 1996 |
Regulatory elements that maintain the anterior boundaries of Hoxc8 expression in neural tube and paraxial mesoderm at later developmental stages are located 11–19 kb downstream of the Hoxc8 gene, demonstrating that long-range cis-regulatory elements govern the late phase of Hoxc8 expression. |
Yeast homologous recombination (pClasper vector) to clone 27 kb genomic region; reporter transgene analysis in transgenic mice |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
8637890
|
| 1998 |
Differences in cis-regulatory sequences of the Hoxc8 early enhancer between chicken and mouse cause a temporal delay in Hoxc8 activation in chicken, restricting its paraxial mesoderm expression to a more posterior domain; transgenic mouse assays show the chicken enhancer directs more posterior reporter expression than the mouse enhancer. |
Comparative sequence analysis; transgenic mouse reporter assays with chicken and mouse Hoxc8 early enhancer constructs |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
9482889
|
| 2006 |
Chromatin immunoprecipitation combined with microarray and high-throughput ChIP identified five direct Hoxc8 target genes (including OPN and Fzd2) out of 34 responsive genes; all five contain Hoxc8 consensus binding sites and encode proteins involved in oncogenesis, cell adhesion, proliferation, and apoptosis. |
Microarray expression profiling, genome-wide Hoxc8 DNA-binding site analysis, high-throughput ChIP |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16793922
|
| 2008 |
Transcription factor Ap2delta associates with Ash2l and the MLL family histone methyltransferase ALR/MLL2 in a complex that trimethylates H3K4; Ap2delta is required for recruitment of this complex to the Hoxc8 locus, leading to H3K4me3 and Hoxc8 transcriptional activation. |
Yeast two-hybrid screen, co-immunoprecipitation, ChIP for Ash2l/Alr and H3K4me3 at Hoxc8 locus, dose-dependent transactivation assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
18495928
|
| 2010 |
Lsh controls CpG methylation at the Hoxc8 locus; in wild-type cells, DNA methylation at Hoxc8 is associated with RNA Pol II stalling (not failure to bind) as the silencing mechanism. In Lsh-/- cells, hypomethylation at Hoxc8 permits efficient Pol II transcriptional elongation facilitated by the chromodomain protein Chd1. |
Lsh knockout mouse cells, DNA methylation analysis, Pol II ChIP, nucleosomal mapping, Chd1 functional assays |
PloS one |
High |
20161795
|
| 2010 |
HOXC8 inhibits androgen receptor (AR)-mediated transcriptional induction in prostate cancer cells by blocking hormone-dependent recruitment of the coactivator SRC-3 and CBP to androgen-regulated gene enhancers, inhibiting histone acetylation; forced SRC-3 expression reverses HOXC8-mediated inhibition, and co-immunoprecipitation shows HOXC8 disrupts the AR–SRC-3 interaction. |
Transient transfection, ChIP for SRC-3/CBP/histone acetylation at PSA enhancer, co-immunoprecipitation, SRC-3 rescue experiment |
Molecular cancer research : MCR |
High |
21047772
|
| 2006 |
Immunoprecipitation of Pbx1 in prostate cancer DU145 cells reveals a Pbx1–HoxC8 heterocomplex; siRNA knockdown of either Pbx1 or HoxC8 suppresses androgen-independent cell growth, and double knockdown suppresses growth more significantly, indicating functional cooperation. |
Co-immunoprecipitation, siRNA knockdown, cell proliferation assay, DNA microarray |
The Prostate |
Medium |
16637071
|
| 2011 |
HOXC8 is required for cadherin 11 (CDH11) expression in breast cancer cells; HOXC8 depletion reduces CDH11 levels, actin-based membrane ruffles, and Rac activity; CDH11 interacts physically with Trio (a Rac GEF) and is required for Trio plasma membrane localization and Rac activation, placing HOXC8 upstream of a CDH11–Trio–Rac signaling axis in cell migration. |
siRNA knockdown, ectopic expression, co-immunoprecipitation (CDH11–Trio), Rac activity assay, active-Rac1 rescue, confocal imaging of membrane ruffles and Trio localization |
Genes & cancer |
High |
22593800
|
| 2014 |
HOXC8 directly binds the CDH11 promoter at nucleotides -196 to -191 and acts as a transcriptional activator; depletion of HOXC8 reduces anchorage-independent growth, migration/invasion, and metastasis, all of which are rescued by ectopic CDH11 expression. |
Chromatin immunoprecipitation, luciferase promoter assay, siRNA knockdown, ectopic CDH11 rescue, soft-agar and invasion assays |
Oncotarget |
High |
24810778
|
| 2015 |
HOXC8 directly binds the embigin (EMB) promoter at nucleotides -2303 to -2315 and acts as a transcriptional repressor; HOXC8 knockdown increases EMB expression, and the pro-tumorigenic effects of HOXC8 knockdown (increased proliferation, migration) are rescued by co-depletion of embigin. |
Western blot, luciferase reporter gene assay, chromatin immunoprecipitation, siRNA knockdown, epistasis rescue experiments |
Oncotarget |
High |
26090721
|
| 2007 |
Endogenous Hoxc8 binds directly to the enhancer region of mouse naked cuticle 2 (mNkd2) gene; introduction of exogenous Hoxc8 into NIH3T3 cells reduces mNkd2 mRNA expression, establishing mNkd2 as a direct transcriptional target through which Hoxc8 cross-talks with the Wnt signaling pathway. |
Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), reporter assay, mRNA expression analysis after Hoxc8 overexpression |
Journal of experimental zoology. Part A, Ecological genetics and physiology |
High |
17094106
|
| 2009 |
Hoxc8 overexpression suppresses basal Smad6 promoter activity and BMP2/Smad1-induced Smad6 transcription; ChIP from mouse embryos shows both Smad1 and Hoxc8 are present at the Smad6 promoter, suggesting Hoxc8 regulates Smad6 indirectly through a complex with Smad1 (no direct Hox binding motif in the Smad6 promoter). |
Promoter luciferase assay, RT-PCR, chromatin immunoprecipitation with anti-Smad1 and anti-Hoxc8 antibodies in mouse embryos |
Molecules and cells |
Medium |
20016939
|
| 2010 |
Proliferating cell nuclear antigen (Pcna) is a direct transcriptional target of Hoxc8; Hoxc8 binds Hox core and Hox-Pbx binding sequences in the Pcna upstream regulatory region (confirmed by ChIP in embryos), overexpression of Hoxc8 increases Pcna transcript levels and cell proliferation rate. |
Chromatin immunoprecipitation in mouse embryos (E11.5), promoter sequence analysis, Hoxc8 overexpression with RT-PCR and proliferation assay |
Biochemical and biophysical research communications |
Medium |
20097160
|
| 2005 |
Retinaldehyde dehydrogenase 2 (Raldh2) conditional knockout causes loss of Lim1+ brachial motoneurons and Islet1+ neuron mispositioning; the molecular basis involves deregulation of Hoxc8, which regulates RARbeta. Hoxc8 mutant mice exhibit the same motoneuron specification defects (phenocopy), establishing Hoxc8 downstream of Raldh2/RA signaling in brachial motoneuron specification. |
Conditional knockout (Raldh2 and Hoxc8 null mice), immunofluorescence for motoneuron markers (Lim1, Islet1), molecular phenotype comparison |
Development (Cambridge, England) |
High |
15753214
|
| 2015 |
LMP1 (EBV) represses HoxC8 expression in nasopharyngeal carcinoma cells via RNA Pol II stalling, partially reversible by irradiation through epigenetic regulator TET3; HoxC8 modulates glycolysis and regulates TCA cycle-related gene expression, and ectopic HoxC8 inhibits NPC cell growth in vitro and in vivo. |
RNA Pol II ChIP, TET3 manipulation, ectopic HoxC8 expression, glycolysis assays, in vivo xenograft |
Oncogene |
Medium |
25745994
|
| 2018 |
HOXC8 functions as a transcriptional activator of TGFβ1, and this elevated TGFβ1 mediates HOXC8-driven proliferation, anchorage-independent growth, migration, and chemoresistance in non-small cell lung cancer cells. |
ChIP, promoter luciferase assay, siRNA knockdown, ectopic overexpression, TGFβ1 blocking rescue experiments, colony formation and migration assays |
Oncogenesis |
Medium |
29367650
|
| 2017 |
ILF3 physically interacts with HOXC8 (co-immunoprecipitation and mass spectrometry) and they cooperate to activate CDH11 transcription; ILF3 binds CDH11 promoter at specific nucleotide positions and requires HOXC8 for co-activation. |
Co-immunoprecipitation, mass spectrometry, ChIP, luciferase reporter assay, siRNA knockdown |
Oncotarget |
Medium |
29296180
|
| 2019 |
HOXC8 directly activates transcription of MGP (matrix Gla protein) by binding its promoter; elevated MGP promotes EMT and drives proliferation and migration specifically in triple-negative breast cancer cells. |
Chromatin immunoprecipitation, luciferase assay, siRNA knockdown and overexpression, EMT marker analysis |
Molecular carcinogenesis |
Medium |
31264274
|
| 2022 |
Sustained Hoxc8 activity is required not only to establish but also to maintain terminal differentiation markers in brachial spinal motor neurons postnatally; conditional inactivation of Hoxc8 at successive developmental stages causes motor deficits, and in vitro-generated MNs show Hoxc8 is sufficient to induce terminal differentiation gene expression directly. |
Conditional Hoxc8 knockout in mice at successive stages, transcriptomics of brachial MNs, motor behavioral assays, in vitro MN generation with Hoxc8 gain/loss-of-function |
eLife |
High |
35315772
|
| 2012 |
Cdx1 directly binds three pairs of conserved Cdx binding sites in the HoxC8 early enhancer during Xenopus embryogenesis (confirmed by ChIP); Cdx1 overexpression or knockdown causes precocious or delayed HoxC8 expression respectively, establishing Cdx1 as a direct transcriptional activator of HoxC8 expression. |
Xenopus Cdx1 overexpression and antisense morpholino knockdown, transgenic reporter (mouse HoxC8 early enhancer in Xenopus), ChIP for Cdx1 binding in embryos, Cdx binding site mutagenesis |
FASEB journal |
High |
22426122
|
| 2017 |
Gdf11/Smad signaling and Cdx proteins synergistically activate the Hoxc8 early enhancer; mutagenesis identified two Smad binding motifs and two Cdx binding motifs as required elements; Gdf11 stimulation is partially inhibited by Specific Inhibitor of Smad3, implicating Smad3 in signal transduction. |
Luciferase reporter transfection in HepG2 cells, Gdf11/Cdx overexpression, site-directed mutagenesis of enhancer motifs, Smad3 inhibitor |
The International journal of developmental biology |
Medium |
28695962
|
| 2008 |
The 16 amino acid third helix (residues 191–206) of the Hoxc8 homeodomain is a protein transduction domain (PTD) sufficient for cellular membrane penetration; transduction efficiency increases with PTD copy number. The homeodomain region of Hoxc8 is also required for forming protein–DNA complexes that can be delivered intracellularly. |
GFP-fusion protein transduction assay in primary pig fibroblasts and COS-7 cells, gel retardation/agarose gel DNA-complex assay, concentration-response and multimer experiments |
Biochemical and biophysical research communications |
Medium |
18835255
|
| 2023 |
HOXC8 activates TGFβ1 transcription and enhances phosphorylated Smad2/Smad3 levels in hepatic stellate cells, creating a positive feedback loop; knockdown of HOXC8 suppresses TGF-β1-induced HSC activation and fibrotic gene (α-SMA, COL1a1) induction in vitro and alleviates liver fibrosis in a CCl4 mouse model in vivo. |
HOXC8 overexpression and knockdown in LX-2 cells and CCl4 mouse model, Western blot for phospho-Smad2/3, qPCR for fibrotic genes, luciferase/ChIP implied by context of TGFβ1 activation claim |
Biochemical and biophysical research communications |
Medium |
37099809
|
| 2025 |
HOXC8 negatively regulates CASP1 (caspase-1) expression by recruiting HDAC1/2 to the CASP1 promoter; HOXC8 and HDAC1 are in the same immunocomplex and HOXC8 is required for HDAC1 recruitment to the CASP1 promoter, suppressing CASP1 transcription and thereby preventing pyroptosis in NSCLC cells. |
Co-immunoprecipitation (HOXC8–HDAC1), ChIP (HOXC8 and HDAC1 at CASP1 promoter), siRNA knockdown, YVAD/disulfiram rescue of pyroptosis, CASP1 forced expression, cholesterol-conjugated siRNA in vivo |
Cell death & disease |
High |
40701951
|
| 2025 |
Hoxc8 is a central pro-fibrotic transcription factor downstream of TGF-β–Smad3 signaling in kidney fibrosis; Hoxc8 reinforces its own expression and drives fibrotic gene programs by recruiting the P-TEFb transcriptional elongation complex; fibroblast-specific Hoxc8 deletion protects mice from renal fibrosis. |
Transcriptomic and cistromic (ChIP-seq implied) analyses, fibroblast-specific conditional Hoxc8 knockout mice, methionine restriction dietary model, histone mark analysis at Hoxc8 locus |
Nature communications |
High |
41476080
|
| 2010 |
miR-196a/b directly targets the HOXC8 3'UTR (confirmed by luciferase reporter), suppressing HOXC8 protein expression; HOXC8 knockdown suppresses breast cancer cell migration and metastasis, and ectopic HOXC8 expression rescues the anti-migratory effect of miR-196, placing HOXC8 downstream of miR-196 in a migration-regulatory axis. |
Luciferase 3'UTR reporter assay, siRNA knockdown, lentiviral miRNA overexpression, in vitro invasion, in vivo spontaneous metastasis assay, HOXC8 ectopic rescue |
Cancer research |
High |
20736365
|
| 2011 |
miR-196a directly interacts with the HOX-C8 3'UTR (confirmed by luciferase assay with different HOX-C8 3'UTR fragments), and stable miR-196a expression down-regulates HOX-C8 in melanoma cells, leading to changes in HOX-C8 target genes cadherin-11, calponin-1, and osteopontin. |
Luciferase 3'UTR reporter assay with deletion fragments, stable miR-196a transfection, target gene expression analysis |
International journal of cancer |
Medium |
21077158
|
| 2020 |
DLX5 and HOXC8 form a protein complex and together bind and negatively regulate the LINC01013 lncRNA promoter; co-expression of DLX5 and HOXC8 enhances chondrogenic differentiation of stem cells from apical papilla (SCAPs) in vitro and restores cartilage defect in a rabbit knee model in vivo. |
Co-immunoprecipitation (DLX5–HOXC8 complex), ChIP at LINC01013 promoter, Western blot, Alcian Blue staining, pellet culture, in vivo rabbit cartilage transplantation |
Stem cell research & therapy |
Medium |
32631410
|
| 2025 |
HOXC8 in cancer-associated fibroblasts (CAFs) directly binds the GCH1 promoter and activates its transcription (confirmed by dual luciferase reporter and bioinformatics); HOXC8-driven GCH1 upregulation suppresses ferroptosis and promotes lung cancer cell malignant progression; si-HOXC8 in CAFs inhibited tumor growth and GCH1 expression in vivo. |
Dual luciferase reporter assay, bioinformatics binding analysis, siRNA knockdown, GCH1 overexpression rescue, xenograft tumor model, IHC |
Pathology, research and practice |
Medium |
41505981
|
| 2025 |
HOXC8 transcriptionally activates TRIM22 expression, leading to ubiquitination and degradation of IκBα and subsequent NF-κB signaling activation; this HOXC8/TRIM22/NF-κB axis drives stemness and chemoresistance in colorectal cancer cells. |
ChIP for HOXC8 at TRIM22 promoter, IκBα ubiquitination assay, NF-κB pathway reporter, siRNA knockdown and overexpression, stemness/sphere-formation assays |
Cancer letters |
Medium |
41265630
|
| 2020 |
HOXC8 overexpression in endometrial stromal cells significantly enhances cell proliferation, migration, adhesion, and fibrotic activities, and increases phosphorylated SMAD2/SMAD3 levels; the adhesion and fibrosis activities induced by HOXC8 are blocked by TGF-β receptor type I kinase inhibitor E-616452, placing HOXC8 upstream of TGF-β/SMAD signaling. |
HOXC8 overexpression in euESCs, cell function assays (proliferation, migration, adhesion, fibrosis), Western blot for phospho-SMAD2/3, pharmacological TGFβRI inhibition |
The Journal of clinical endocrinology and metabolism |
Medium |
32877504
|
| 2008 |
Morpholino-mediated knockdown of Hoxc8 in primary chondrocytes reduces cell proliferation (decreased PCNA expression and phospho-histone H3) without apoptosis, and causes cells to be delayed in M-phase progression, implicating Hoxc8 in cell cycle control at the M-phase checkpoint. |
Morpholino antisense knockdown in primary chondrocytes, PCNA immunostaining, phospho-Histone H3 staining, BrdU incorporation, flow cytometry |
Bone |
Medium |
19071237
|